IRF8 Gene Immunodeficiency Type 32A Mycobacteriosis Autosomal Dominant Genetic Test sale cost 4400 AED
LIPN Gene Ichthyosis lamellar type 4 Genetic Test sale cost 4400 AED LIPN Gene Ichthyosis lamellar type 4 Genetic Test Cost 5,600 د.إ Original price was: 5,600 د.إ.4,400 د.إCurrent price is: 4,400 د.إ.
FOXP3 Gene Immunodysregulation Polyendocrinopathy and Enteropathy X-Linked Genetic Test sale cost 4400 AED FOXP3 Gene Immunodysregulation Polyendocrinopathy and Enteropathy X-Linked Genetic Test Cost 5,600 د.إ Original price was: 5,600 د.إ.4,400 د.إCurrent price is: 4,400 د.إ.
Sale!

IRF8 Gene Immunodeficiency Type 32A Mycobacteriosis Autosomal Dominant Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The IRF8 Gene Immunodeficiency Type 32A Mycobacteriosis Autosomal Dominant Genetic Test is a specialized diagnostic assessment available at DNA Labs UAE, designed to identify mutations in the IRF8 gene, which are linked to a rare immunodeficiency disorder. This condition, known as Immunodeficiency 32A, makes affected individuals highly susceptible to mycobacterial infections, including both typical and atypical mycobacteriosis, due to a compromised immune response. The test is crucial for individuals who have a family history of the disorder or present with symptoms indicative of a compromised immune system, especially an unusual susceptibility to mycobacterial infections.

The test is performed using a sample of the patient’s blood or saliva, from which DNA is extracted and analyzed for specific mutations in the IRF8 gene that are known to cause the disorder. This genetic test is autosomal dominant, meaning that only one copy of the altered gene in each cell is sufficient to cause the disorder, making it vital for at-risk individuals or those with a family history of the condition to undergo testing.

At DNA Labs UAE, the cost for the IRF8 Gene Immunodeficiency Type 32A Mycobacteriosis Autosomal Dominant Genetic Test is set at 4400 AED. The price reflects the comprehensive nature of the test, encompassing the advanced genetic analysis required to accurately identify the presence of the IRF8 gene mutations. This test not only aids in the diagnosis of the condition but also assists in the development of a personalized treatment plan to manage the symptoms and improve the quality of life for those affected.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

IRF8 Gene Immunodeficiency Type 32A Mycobacteriosis Autosomal Dominant Genetic Test

Test Name: IRF8 Gene Immunodeficiency Type 32A Mycobacteriosis Autosomal Dominant Genetic Test

Components: DNA Labs UAE

Price: 4400.0 AED

Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card

Report Delivery: 3 to 4 Weeks

Method: NGS Technology

Test Type: Osteology Dermatology Immunology Disorders

Doctor: Dermatologist

Test Department: Genetics

Pre Test Information: Clinical History of Patient who is going for IRF8 Gene Immunodeficiency Type 32A, Mycobacteriosis, Autosomal Dominant NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with IRF8 Gene Immunodeficiency Type 32A, Mycobacteriosis, Autosomal Dominant NGS Genetic DNA Test gene IRF8

Test Details: IRF8 gene immunodeficiency type 32A, also known as mycobacteriosis, is a rare genetic disorder that affects the immune system’s ability to fight off certain types of bacteria, specifically mycobacteria. It is an autosomal dominant condition, which means that a person only needs to inherit one copy of the mutated gene from either parent to develop the disease. NGS genetic testing, or Next-Generation Sequencing genetic testing, is a type of genetic test that uses advanced sequencing technology to analyze a person’s DNA. This test can identify mutations or variations in the IRF8 gene that are associated with immunodeficiency type 32A. By identifying these mutations, healthcare providers can diagnose individuals with this condition and provide appropriate medical management and treatment.

The symptoms of IRF8 gene immunodeficiency type 32A typically manifest as recurrent or severe infections caused by mycobacteria, such as tuberculosis or atypical mycobacterial infections. These infections can affect various parts of the body, including the lungs, skin, lymph nodes, and bones. Other symptoms may include fever, weight loss, fatigue, and respiratory problems.

Treatment for IRF8 gene immunodeficiency type 32A usually involves a combination of antimicrobial medications to control and prevent mycobacterial infections. In some cases, individuals may also require immunoglobulin replacement therapy to boost their immune system’s ability to fight off infections.

Genetic counseling is recommended for individuals and families affected by this condition to understand the inheritance pattern and the risk of passing it on to future generations.

Test Name IRF8 Gene Immunodeficiency type 32A mycobacteriosis autosomal dominant Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Osteology Dermatology Immunology Disorders
Doctor Dermatologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for IRF8 Gene Immunodeficiency type 32A, mycobacteriosis, autosomal dominant NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with IRF8 Gene Immunodeficiency type 32A, mycobacteriosis, autosomal dominant NGS Genetic DNA Test gene IRF8
Test Details

IRF8 gene immunodeficiency type 32A, also known as mycobacteriosis, is a rare genetic disorder that affects the immune system’s ability to fight off certain types of bacteria, specifically mycobacteria. It is an autosomal dominant condition, which means that a person only needs to inherit one copy of the mutated gene from either parent to develop the disease.

NGS genetic testing, or Next-Generation Sequencing genetic testing, is a type of genetic test that uses advanced sequencing technology to analyze a person’s DNA. This test can identify mutations or variations in the IRF8 gene that are associated with immunodeficiency type 32A. By identifying these mutations, healthcare providers can diagnose individuals with this condition and provide appropriate medical management and treatment.

The symptoms of IRF8 gene immunodeficiency type 32A typically manifest as recurrent or severe infections caused by mycobacteria, such as tuberculosis or atypical mycobacterial infections. These infections can affect various parts of the body, including the lungs, skin, lymph nodes, and bones. Other symptoms may include fever, weight loss, fatigue, and respiratory problems.

Treatment for IRF8 gene immunodeficiency type 32A usually involves a combination of antimicrobial medications to control and prevent mycobacterial infections. In some cases, individuals may also require immunoglobulin replacement therapy to boost their immune system’s ability to fight off infections. Genetic counseling is recommended for individuals and families affected by this condition to understand the inheritance pattern and the risk of passing it on to future generations.

SKU: TEST-3085 Category:

Related products